Arrowhead Pharmaceuticals Total Assets 2006-2019 | ARWR

Arrowhead Pharmaceuticals total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Arrowhead Pharmaceuticals Annual Total Assets
(Millions of US $)
2019 $350
2018 $112
2017 $104
2016 $128
2015 $132
2014 $183
2013 $37
2012 $17
2011 $16
2010 $12
2009 $8
2008 $17
2007 $30
2006 $35
2005 $29
Arrowhead Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2019-12-31 $588
2019-09-30 $350
2019-06-30 $337
2019-03-31 $334
2018-12-31 $341
2018-09-30 $112
2018-06-30 $113
2018-03-31 $127
2017-12-31 $88
2017-09-30 $104
2017-06-30 $115
2017-03-31 $127
2016-12-31 $144
2016-09-30 $128
2016-06-30 $86
2016-03-31 $95
2015-12-31 $111
2015-09-30 $132
2015-06-30 $145
2015-03-31 $162
2014-12-31 $162
2014-09-30 $183
2014-06-30 $197
2014-03-31 $203
2013-12-31 $93
2013-09-30 $37
2013-06-30 $41
2013-03-31 $12
2012-12-31 $15
2012-09-30 $17
2012-06-30 $16
2012-03-31 $20
2011-12-31 $23
2011-09-30 $16
2011-06-30 $13
2011-03-31 $15
2010-12-31 $15
2010-09-30 $12
2010-06-30 $15
2010-03-31 $8
2009-12-31 $9
2009-09-30 $8
2009-06-30 $8
2009-03-31 $10
2008-12-31 $15
2008-09-30 $17
2008-06-30 $19
2008-03-31 $25
2007-12-31 $31
2007-09-30 $30
2007-06-30 $37
2007-03-31 $27
2006-12-31 $34
2006-09-30 $35
2006-06-30 $41
2006-03-31 $45
2005-12-31 $26
2005-09-30 $29
2005-06-30 $31
2005-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.859B $0.169B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.083B 30.71
Takeda Pharmaceutical (TAK) Japan $48.710B 8.54
Astellas Pharma (ALPMY) Japan $28.984B 14.48
Eisai (ESALY) Japan $20.745B 38.65
UCB SA (UCBJF) Belgium $16.296B 0.00
Grifols, S.A (GRFS) Spain $14.198B 17.65
Merck (MKGAF) Germany $13.006B 17.06
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.172B 227.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.163B 29.47
Ionis Pharmaceuticals (IONS) United States $6.879B 20.85
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.480B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.443B 6.64
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.553B 0.00
IPSEN SA ADR (IPSEY) France $4.515B 0.00
United Therapeutics (UTHR) United States $4.008B 0.00
Hypermarcas (HYPMY) Brazil $3.914B 11.90
Evotec AG (EVTCY) Germany $3.485B 56.21
Nektar Therapeutics (NKTR) United States $3.059B 0.00
FibroGen (FGEN) United States $2.945B 0.00
PTC Therapeutics (PTCT) United States $2.527B 0.00
ChemoCentryx (CCXI) United States $2.376B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.271B 9.19
Sage Therapeutics (SAGE) United States $1.635B 0.00
Xencor (XNCR) United States $1.621B 66.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.613B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.550B 18.85
Pacira Pharmaceuticals (PCRX) United States $1.334B 36.47
Theravance Biopharma (TBPH) Cayman Islands $1.331B 0.00
Karyopharm Therapeutics (KPTI) United States $1.283B 0.00
USANA Health Sciences (USNA) United States $1.279B 13.43
Corcept Therapeutics (CORT) United States $1.246B 13.94
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Zogenix (ZGNX) United States $1.060B 0.00
Heron Therapeutics (HRTX) United States $1.021B 0.00
Esperion Therapeutics (ESPR) United States $0.971B 0.00
Tilray (TLRY) Canada $0.947B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 29.03
Akebia Therapeutics (AKBA) United States $0.916B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.898B 12.50
Endo (ENDP) Ireland $0.787B 1.45
Translate Bio (TBIO) United States $0.649B 0.00
ImmunoGen (IMGN) United States $0.645B 0.00
Molecular Templates (MTEM) United States $0.645B 0.00
Radius Health (RDUS) United States $0.608B 0.00
Aerie Pharmaceuticals (AERI) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.561B 0.00
Portola Pharmaceuticals (PTLA) United States $0.536B 0.00
Indivior (INVVY) United States $0.480B 2.85
Catalyst Pharmaceuticals (CPRX) United States $0.390B 13.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Siga Technologies (SIGA) United States $0.384B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.378B 15.51
Corbus Pharmaceuticals Holdings (CRBP) United States $0.377B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Ardelyx (ARDX) United States $0.368B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.356B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.339B 0.00
Trillium Therapeutics (TRIL) Canada $0.328B 0.00
Flexion Therapeutics (FLXN) United States $0.317B 0.00
Calithera Biosciences (CALA) United States $0.311B 0.00
DURECT (DRRX) United States $0.305B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.295B 0.00
TherapeuticsMD (TXMD) United States $0.293B 0.00
Lannett Co Inc (LCI) United States $0.292B 4.71
Harpoon Therapeutics (HARP) United States $0.286B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.265B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.263B 0.00
Ocular Therapeutix (OCUL) United States $0.259B 0.00
CASI Pharmaceuticals (CASI) United States $0.206B 0.00
OptiNose (OPTN) United States $0.184B 0.00
Rafael Holdings (RFL) United States $0.183B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 2.90
Recro Pharma (REPH) United States $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.152B 19.10
PROFOUND MEDICL (PROF) Canada $0.146B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Taiwan Liposome (TLC) Taiwan $0.139B 0.00
KalVista Pharmaceuticals (KALV) United States $0.130B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.119B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.102B 0.00
CannTrust Holdings (CTST) Canada $0.099B 0.00
Redhill Biopharma (RDHL) Israel $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.086B 0.00
IMV INC (IMV) Canada $0.084B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.081B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Xeris Pharmaceuticals (XERS) United States $0.077B 0.00
Aquestive Therapeutics (AQST) United States $0.077B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.069B 0.00
Biomerica (BMRA) United States $0.069B 0.00
Otonomy (OTIC) United States $0.063B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 16.43
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
MediWound (MDWD) Israel $0.045B 0.00
Onconova Therapeutics (ONTX) United States $0.044B 0.00
PharmAthene (ALT) United States $0.044B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.043B 19.41
Neos Therapeutics (NEOS) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.14
Forward Pharma (FWP) Denmark $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.037B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.05
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
Novan (NOVN) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
China SXT Pharmaceuticals (SXTC) China $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
ElectroCore (ECOR) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
KemPharm (KMPH) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00